Think ahead: Preparing for challenges to accelerate your cell therapy commercialization

CAR T therapies are gaining increased attention due to their demonstrated potential in patient outcomes. For a successful commercialization of these therapies, it’s critical to not only have a safe and effective therapy, but to establish a cost-effective and reliable manufacturing process. During this webinar, we'll discuss how decisions made during the early development stages of the process can have long-lasting effects.

Too often, advanced therapy companies ignore the important consequences of decisions made during the early development. Let’s discuss how to avoid potential future pain by thinking about critical factors necessary for the successful commercialization of an advanced therapy such as:
- Contamination risk
- Inconsistent process prone to human errors
- Non-scalable process
- High COGs due to labor-intensive process in a high classification cleanroom

Understand all the benefits of implementing the appropriate closed and automated process during early clinical trials such as:
- Scalability
- COGs optimization
- Process integrity

Learn more at cytiva.com/CAR-T.